Sola Diagnostics

Innsbruck, Austria

Sola Dx develops and markets minimally invasive epigenetics based test for early cancer detection and prediction.

$417K raised

Feb 2025

Seed

Biotechnology Health Diagnostics

Top Investors

FPS-Holding

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Sola Diagnostics

How much funding has Sola Diagnostics raised?

Sola Diagnostics has raised $417K in total funding. The most recent round was Seed. The last funding was announced in February 2025.

Who are Sola Diagnostics's investors?

Sola Diagnostics's investors include FPS-Holding.

Where is Sola Diagnostics headquartered?

Sola Diagnostics is headquartered in Innsbruck, Austria.

What does Sola Diagnostics do?

Sola Dx develops and markets minimally invasive epigenetics based test for early cancer detection and prediction.

What stage is Sola Diagnostics at?

Sola Diagnostics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 20, 2025.

MLA

"Sola Diagnostics — Funding & Investors." VCBacked, February 20, 2025, https://www.vcbacked.co/company/sola-diagnostics. Accessed June 17, 2026.

APA

VCBacked. (2025). Sola Diagnostics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/sola-diagnostics

Wikipedia (cite web)

{{cite web |title=Sola Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/sola-diagnostics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 20, 2025.

Similar Companies in Biotechnology